FDA prioritizing review for Pfizer-BioNTech COVID-19 vaccine approval, companies say

The Food and Drug Administration has granted priority review for the approval of the Pfizer-BioNTech COVID-19 shots for people aged 16 years and older, the vaccine makers said Friday.

The FDA is striving to make a decision in January, according to Pfizer and BioNTech.

The companies said they completed the …

For the full story: Read More

Leave a Reply

Your email address will not be published. Required fields are marked *